MDODX
Price
$9.96
Change
+$0.08 (+0.81%)
Updated
Jan 17 closing price
Net Assets
30.53M
RNWEX
Price
$77.31
Change
+$0.35 (+0.45%)
Updated
Jan 17 closing price
Net Assets
62.57B
Ad is loading...

MDODX vs RNWEX

Header iconMDODX vs RNWEX Comparison
Open Charts MDODX vs RNWEXBanner chart's image
Morgan Stanley Developing Opportunity R6
Price$9.96
Change+$0.08 (+0.81%)
VolumeN/A
Net Assets30.53M
American Funds New World R4
Price$77.31
Change+$0.35 (+0.45%)
VolumeN/A
Net Assets62.57B
MDODX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDODX vs. RNWEX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDODX is a StrongBuy and RNWEX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 62.6B vs. MDODX (30.5M). RNWEX pays higher dividends than MDODX: RNWEX (1.24) vs MDODX (0.00). MDODX was incepted earlier than RNWEX: MDODX (5 years) vs RNWEX (22 years). RNWEX is a more actively managed with annual turnover of: 32.00 vs. MDODX (15.00). RNWEX has a lower initial minimum investment than MDODX: RNWEX (250) vs MDODX (5000000). MDODX annual gain was more profitable for investors over the last year : 21.95 vs. RNWEX (7.10).
MDODXRNWEXMDODX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years22 years-
Gain YTD-0.8961.072-84%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets30.5M62.6B0%
Annual Yield % from dividends0.001.24-
Returns for 1 year21.957.10309%
Returns for 3 years-7.84-3.47226%
Returns for 5 yearsN/A10.11-
Returns for 10 yearsN/A48.80-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STRO2.010.16
+8.65%
Sutro Biopharma
ACM108.931.08
+1.00%
Aecom
BANF119.750.95
+0.80%
BancFirst Corp
TSBX0.44-0.02
-4.75%
Turnstone Biologics Corp
CRMD12.17-0.62
-4.85%
CorMedix